Denali Capital Acquisition Corp. Files Q1 2025 10-Q
Ticker: SMNRW · Form: 10-Q · Filed: May 16, 2025 · CIK: 1913577
| Field | Detail |
|---|---|
| Company | Denali Capital Acquisition Corp. (SMNRW) |
| Form Type | 10-Q |
| Filed Date | May 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, financials
TL;DR
Denali Capital Acquisition Corp. filed its Q1 2025 10-Q. Financials are in.
AI Summary
Denali Capital Acquisition Corp. filed its 10-Q for the quarterly period ended March 31, 2025. The company, incorporated in the Cayman Islands with its principal executive offices in New York, NY, is involved in the Pharmaceutical Preparations industry. The filing details its financial performance and operations for the specified period.
Why It Matters
This filing provides investors and analysts with a quarterly update on Denali Capital Acquisition Corp.'s financial health and operational status, crucial for understanding its performance and future prospects.
Risk Assessment
Risk Level: low — This is a standard quarterly filing (10-Q) providing financial updates, not indicating immediate operational or financial distress.
Key Players & Entities
- Denali Capital Acquisition Corp. (company) — Registrant
- March 31, 2025 (date) — Quarterly period end date
- 001-41351 (company) — Commission File Number
- 437 Madison Avenue, 27th Floor New York, New York 10022 (company) — Principal Executive Offices Address
- 2834 (company) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the fiscal year end for Denali Capital Acquisition Corp.?
The fiscal year end for Denali Capital Acquisition Corp. is December 31.
What is the Standard Industrial Classification code for Denali Capital Acquisition Corp.?
The Standard Industrial Classification code for Denali Capital Acquisition Corp. is 2834, which corresponds to Pharmaceutical Preparations.
Where are Denali Capital Acquisition Corp.'s principal executive offices located?
Denali Capital Acquisition Corp.'s principal executive offices are located at 437 Madison Avenue, 27th Floor, New York, New York 10022.
What is the Commission File Number for Denali Capital Acquisition Corp.?
The Commission File Number for Denali Capital Acquisition Corp. is 001-41351.
What is the filing date of this 10-Q report?
This 10-Q report was filed on May 16, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 16, 2025 regarding Denali Capital Acquisition Corp. (SMNRW).